C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2004
11/30/2004	US6825360 Bicyclic aromatic compounds
11/30/2004	US6825352 Preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitors
11/30/2004	US6825351 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (r)- and (s)-forms
11/30/2004	US6825235 Synthesis of taxol enhancers
11/30/2004	US6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
11/30/2004	US6825201 Indole, azaindole and related heterocyclic amidopiperazine derivatives
11/25/2004	WO2004101507A2 N-sulphonylated amino acid derivatives and use thereof as matriptase inhibitors
11/25/2004	WO2004101505A1 Novel compounds for treatment of obesity
11/25/2004	WO2004101495A1 Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
11/25/2004	WO2004100998A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/25/2004	WO2004085385A3 Cannabinoid receptor ligands
11/25/2004	WO2004084842A3 Inhibitors of cathepsin s
11/25/2004	WO2004069133A3 N-monoacylated o-phenylenediamines as anti -cancer agents
11/25/2004	US20040236151 Process to produce enantiomerically enriched 1-aryl-and 1-heteroaryl-2-aminoethanols
11/25/2004	US20040236120 Oxydehydrogenating n-butenes to 1,3-butadiene in the feed-side reaction zone, and oxidation of 1,3-butadiene to maleic anhydride in the product-side reaction zone of a shell-and-tube reactor; mixed oxide catalysts; high conversion, selectivity
11/25/2004	US20040236115 Synthesis of cyclopentadiene derivatives
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004	US20040235927 Synthesis and antimicrobial activity of novel dicationic "reversed amidines"
11/25/2004	US20040235914 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235909 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235852 Benzofuran inhibitors of factor VIIa
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	US20040231064 3-Aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
11/25/2004	DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/25/2004	CA2525886A1 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors
11/24/2004	EP1479673A1 Method of obtaining citalopram
11/24/2004	EP1478731A1 Phenalenone derivatives, method for the production thereof and use of the same
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478638A1 Purification of citalopram
11/24/2004	EP1478637A1 Amorphous citalopram salts
11/24/2004	EP1478636A1 Amorphous citalopram
11/24/2004	EP1478635A1 Process for the production of citalopram
11/24/2004	EP1478634A1 Furanone derivatives
11/24/2004	EP1478629A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
11/24/2004	EP1478617A1 Polyol ester compounds useful in preparation of a catalyst for olefins polymerization, process for preparing the same and use thereof
11/24/2004	EP1478614A1 Method for producing phthalic anhydride
11/24/2004	EP1478364A2 Selective antibacterial agents
11/24/2004	EP1478225A2 Brassica seeds
11/24/2004	EP1406890A4 Phthalide compounds useful in optical recording
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs
11/24/2004	CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques
11/24/2004	CN1548430A Supercritical CO2 extraction process for refining neotanshinone IIA from red sage
11/24/2004	CN1548429A Andrographolide-trimaleate and its salt and their medicine composition
11/24/2004	CN1548428A Carboxylic acid derivatives having fused rings
11/24/2004	CN1548427A Prepn process and apparatus for alpha-acetyl-gamma-butyrolactone
11/24/2004	CN1176651C N-(3-benzofuryl) urea derivative
11/23/2004	US6822101 Reacting 1-(3-butynyl)-pyrrolidine or -piperidine with phenolic compound; cyclization; treating with boronic acid derivative; histamine-3 receptor ligands
11/23/2004	US6821963 4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
11/18/2004	WO2004099880A1 Organic photoconductive material and, using the same, electrophotographic photoreceptor and image forming device
11/18/2004	WO2004099175A2 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	WO2004099171A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099170A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099168A2 Substituted carboxylic acids
11/18/2004	WO2004099145A2 Phenyl substituted cyclic derivatives
11/18/2004	WO2004099125A1 Method for crystallizing guanidinium salts
11/18/2004	WO2004099124A2 Novel bioisosteres of actinonin
11/18/2004	WO2004099105A2 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
11/18/2004	WO2004098611A1 Fortifier
11/18/2004	WO2004098284A2 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
11/18/2004	WO2004098283A2 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
11/18/2004	WO2004026853A3 Method for producing tetrahydrofuran
11/18/2004	US20040230079 alkoxide and hydroxide induced nucleophilic trifluoromethylation of carbonyl compounds, disulfides and other electrophiles, using phenyl trifluoromethyl sulfone PhSO2CF3 (or sulfoxide PhSOCF3); high diastereoselectivity; preparing 2,2-difluoropropan-diols directly from carbonyl compounds
11/18/2004	US20040230066 Production method of citalopram, intermediate therefor and production method of the intermediate
11/18/2004	US20040230065 Process for the preparation of 5-substituted isobenzofurans
11/18/2004	US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229952 a thiohydrazide product compound prepared by reacting a hydrazide starting compound with a thionylating reagent; anticancer agents
11/18/2004	US20040229935 Cytotoxic compounds
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229918 Phosphodiesterase 4 inhibitors
11/18/2004	US20040229915 Cysteine protease inhibitors
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	US20040229909 Antiviral agent
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229846 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
11/18/2004	CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	CA2524718A1 Method for crystallizing guanidinium salts
11/18/2004	CA2524235A1 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523718A1 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523714A1 Substituted carboxylic acids
11/18/2004	CA2523231A1 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
11/18/2004	CA2523191A1 Phenyl substituted cyclic derivatives
11/18/2004	CA2523085A1 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
11/18/2004	CA2522857A1 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477485A1 Aminophenol derivatives
11/17/2004	EP1477483A1 Vitamin d3 derivatives and remedies using the same
11/17/2004	EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004	EP1477475A1 Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1476149A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
11/17/2004	EP1412335A4 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides

1 ... 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 ... 472